Donaldson Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.94M | Buy |
65,027
+3,905
| +6% | +$228K | 0.13% | 81 |
|
|
2025
Q4 | $3.3M | Buy |
61,122
+1,900
| +3% | +$91.4K | 0.1% | 87 |
|
|
2025
Q3 | $2.67M | Buy |
59,222
+583
| +1% | +$27.2K | 0.08% | 96 |
|
|
2025
Q2 | $2.71M | Sell |
58,639
-2,806
| -5% | -$138K | 0.1% | 92 |
|
|
2025
Q1 | $3.75M | Buy |
61,445
+2,050
| +3% | +$119K | 0.14% | 75 |
|
|
2024
Q4 | $3.36M | Buy |
59,395
+22,653
| +62% | +$1.27M | 0.13% | 80 |
|
|
2024
Q3 | $1.9M | Sell |
36,742
-3,655
| -9% | -$171K | 0.07% | 109 |
|
|
2024
Q2 | $1.68M | Sell |
40,397
-599,458
| -94% | -$26.8M | 0.07% | 108 |
|
|
2024
Q1 | $34.7M | Buy |
639,855
+33,552
| +6% | +$1.71M | 1.44% | 31 |
|
|
2023
Q4 | $31.1M | Sell |
606,303
-76,431
| -11% | -$4.01M | 1.39% | 32 |
|
|
2023
Q3 | $39.6M | Buy |
682,734
+16,880
| +3% | +$1.03M | 1.87% | 24 |
|
|
2023
Q2 | $42.6M | Buy |
665,854
+103,506
| +18% | +$6.94M | 1.94% | 25 |
|
|
2023
Q1 | $39M | Buy |
562,348
+510,660
| +988% | +$36M | 1.84% | 31 |
|
|
2022
Q4 | $3.72M | Sell |
51,688
-169
| -0.3% | -$12.7K | 0.18% | 67 |
|
|
2022
Q3 | $3.69M | Buy |
51,857
+1,614
| +3% | +$117K | 0.2% | 65 |
|
|
2022
Q2 | $3.87M | Buy |
50,243
+119
| +0.2% | +$9.06K | 0.2% | 64 |
|
|
2022
Q1 | $3.66M | Buy |
50,124
+195
| +0.4% | +$13.1K | 0.17% | 69 |
|
|
2021
Q4 | $3.11M | Sell |
49,929
-630
| -1% | -$37K | 0.14% | 73 |
|
|
2021
Q3 | $2.99M | Sell |
50,559
-1,335
| -3% | -$87.9K | 0.15% | 74 |
|
|
2021
Q2 | $3.47M | Sell |
51,894
-227
| -0.4% | -$14.8K | 0.18% | 72 |
|
|
2021
Q1 | $3.29M | Buy |
52,121
+380
| +0.7% | +$23.6K | 0.18% | 71 |
|
|
2020
Q4 | $3.21M | Sell |
51,741
-147
| -0.3% | -$9.04K | 0.19% | 65 |
|
|
2020
Q3 | $3.13M | Hold |
51,888
| – | – | 0.21% | 64 |
|
|
2020
Q2 | $3.05M | Hold |
51,888
| – | – | 0.22% | 60 |
|
|
2020
Q1 | $2.89M | Sell |
51,888
-1,703
| -3% | -$104K | 0.25% | 54 |
|
|
2019
Q4 | $3.44M | Buy |
53,591
+2,616
| +5% | +$150K | 0.23% | 62 |
|
|
2019
Q3 | $2.58M | Buy |
50,975
+42,506
| +502% | +$2M | 0.19% | 70 |
|
|
2019
Q2 | $384K | Sell |
8,469
-788
| -9% | -$36.7K | 0.03% | 118 |
|
|
2019
Q1 | $442K | Hold |
9,257
| – | – | 0.04% | 108 |
|
|
2018
Q4 | $481K | Sell |
9,257
-450
| -5% | -$24.2K | 0.05% | 102 |
|
|
2018
Q3 | $603K | Sell |
9,707
-536
| -5% | -$31.8K | 0.05% | 106 |
|
|
2018
Q2 | $567K | Sell |
10,243
-711
| -6% | -$38.4K | 0.06% | 100 |
|
|
2018
Q1 | $693K | Sell |
10,954
-2,452
| -18% | -$158K | 0.07% | 98 |
|
|
2017
Q4 | $822K | Sell |
13,406
-418
| -3% | -$26.1K | 0.08% | 92 |
|
|
2017
Q3 | $881K | Buy |
13,824
+162
| +1% | +$9.46K | 0.09% | 86 |
|
|
2017
Q2 | $761K | Sell |
13,662
-699
| -5% | -$38K | 0.09% | 90 |
|
|
2017
Q1 | $781K | Sell |
14,361
-2,631
| -15% | -$144K | 0.09% | 87 |
|
|
2016
Q4 | $993K | Buy |
16,992
+739
| +5% | +$40.4K | 0.12% | 80 |
|
|
2016
Q3 | $876K | Sell |
16,253
-3,399
| -17% | -$218K | 0.12% | 72 |
|
|
2016
Q2 | $1.45M | Buy |
19,652
+3,263
| +20% | +$231K | 0.2% | 58 |
|
|
2016
Q1 | $1.05M | Sell |
16,389
-199
| -1% | -$12.6K | 0.15% | 62 |
|
|
2015
Q4 | $1.14M | Buy |
16,588
+1,493
| +10% | +$98.7K | 0.17% | 58 |
|
|
2015
Q3 | $894K | Buy |
15,095
+1,772
| +13% | +$112K | 0.13% | 66 |
|
|
2015
Q2 | $887K | Hold |
13,323
| – | – | 0.13% | 69 |
|
|
2015
Q1 | $859K | Sell |
13,323
-2,294
| -15% | -$144K | 0.12% | 69 |
|
|
2014
Q4 | $922K | Buy |
15,617
+3,708
| +31% | +$209K | 0.14% | 68 |
|
|
2014
Q3 | $609K | Sell |
11,909
-576
| -5% | -$28.8K | 0.1% | 78 |
|
|
2014
Q2 | $606K | Sell |
12,485
-198
| -2% | -$9.76K | 0.1% | 79 |
|
|
2014
Q1 | $659K | Buy |
12,683
+601
| +5% | +$32K | 0.12% | 67 |
|
|
2013
Q4 | $642K | Buy |
12,082
+150
| +1% | +$7.64K | 0.12% | 64 |
|
|
2013
Q3 | $552K | Sell |
11,932
-1,365
| -10% | -$59.9K | 0.12% | 64 |
|
|
2013
Q2 | $594K | Buy |
+13,297
| New | +$577K | 0.13% | 61 |
|
Other funds holding BMY
VCM
VPM
Donaldson Capital Management's BMY Position: Q1 2026 in Review
Donaldson Capital Management increased its Bristol-Myers Squibb (BMY) stake by 6.4% in Q1 2026, buying an estimated $228K and bringing the position to 65,027 shares worth $3.94M. The position accounts for 0.13% of the portfolio, ranked #81.
Donaldson Capital Management first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $42.6M in Q2 2023. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Donaldson Capital Management held 65,027 shares of Bristol-Myers Squibb worth $3.94M as of Q1 2026.
- Donaldson Capital Management bought 3,905 Bristol-Myers Squibb shares in Q1 2026, an estimated $228K.
- Bristol-Myers Squibb made up 0.13% of Donaldson Capital Management's portfolio in Q1 2026, its #81 holding.
- Donaldson Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Donaldson Capital Management's Bristol-Myers Squibb position peaked at $42.6M in Q2 2023.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Donaldson Capital Management's 13F filing for Q1 2026, filed 30 Apr 2026.